Studies of the mode of action of the sulfonylureas and phenylacetamides in enhancing the effect of vasopressin.
D000082:Acetaminophen / Q000494:pharmacology*; D000067956:Adenylyl Cyclase Inhibitors; D000818:Animals; D002024:Bufo marinus; D002747:Chlorpropamide / Q000494:pharmacology*; D000242:Cyclic AMP / Q000037:antagonists & inhibitors / Q000494:pharmacology; D004357:Drug Synergism; D066298:In Vitro Techniques; D009995:Osmosis / Q000187:drug effects; D010615:Phenacetin / Q000494:pharmacology*; D010744:Phosphoric Monoester Hydrolases / Q000037:antagonists & inhibitors; D011453:Prostaglandins / Q000494:pharmacology; D013268:Stimulation, Chemical; D013453:Sulfonylurea Compounds / Q000494:pharmacology*; D013806:Theophylline / Q000494:pharmacology; D014316:Tritium; D001743:Urinary Bladder / Q000187:drug effects / Q000502:physiology; D014667:Vasopressins / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D014867:Water / Q000378:metabolism
D000067956:Adenylyl Cyclase Inhibitors; D011453:Prostaglandins; D013453:Sulfonylurea Compounds; D014867:Water; D014316:Tritium; D014667:Vasopressins; D000082:Acetaminophen; D013806:Theophylline; D000242:Cyclic AMP; D010744:Phosphoric Monoester Hydrolases; D010615:Phenacetin; D002747:Chlorpropamide